Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Almirall

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Almirall's 2013 sales performance.

Deal Watch table for November 2014

Deal Watch table for November 2014 Pharma business unit. Business unit divestment. 3, 200. Almirall / AstraZeneca.

AZ's new COPD therapy gets green light in Europe

AZ's new COPD therapy gets green light in Europe AZ owns the rights to develop and commercialise Duaklir in the EU after taking ownership of former partner Almirall's respiratory portfolio in a $1.2bn deal that was completed last

Red Door promotes Matt Lowe and Katy Pogson

Red Door promotes Matt Lowe and Katy Pogson Aldous joined Red Door in 2011 from Red Health as a senior account manager and currently leads accounts for Sanofi, MSD, Baxter, Almirall and Astellas.

EMA backs 15 new medicines for use in EU

EMA backs 15 new medicines for use in EU AstraZeneca and Almirall. There was good news for AstraZeneca (AZ), which received positive opinions for two of its medicines. ... Aclidinium / formoterol fumarate, which is set to be marketed as Brimica Genuair or Duaklir Genuair depending on the country

The M&A trend in pharma

The M&A trend in pharma It is also driving acquisitions that complement the buyer's existing core products, as evidenced by AstraZeneca's $1.2bn acquisition of Almirall's respiratory division and the deal between GSK

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics